EMA considers azithromycin heart warning

15:02 EDT 15 Mar 2013 | Pharmaceutical Journal

The European Medicines Agency is considering whether to strengthen warnings about the risk of potentially fatal arrhythmias in azithromycin prescribing information. A safety announcement was issued by the US Food and Drug Administration this week (1...

Original Article: EMA considers azithromycin heart warning

NEXT ARTICLE

More From BioPortfolio on "EMA considers azithromycin heart warning"

Search BioPortfolio:
Loading